Multicenter Registry of High-Risk Percutaneous Coronary Intervention and Adequate Platelet Inhibition

Trial Profile

Multicenter Registry of High-Risk Percutaneous Coronary Intervention and Adequate Platelet Inhibition

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Apr 2007

At a glance

  • Drugs Eptifibatide (Primary) ; Tirofiban (Primary) ; Clopidogrel
  • Indications Coronary artery disease; Embolism and thrombosis
  • Focus Pharmacodynamics
  • Acronyms MR-PCI
  • Most Recent Events

    • 24 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top